Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device
Primary Purpose
Arthroplasty of the MCP Joint
Status
Approved for marketing
Phase
Locations
United States
Study Type
Expanded Access
Intervention
SR™MCP
Sponsored by

About this trial
This is an expanded access trial for Arthroplasty of the MCP Joint focused on measuring osteo-arthritis, post traumatic arthritis
Eligibility Criteria
Inclusion Criteria:
- patient is in need of a revision of failed MCP prosthesis(es)
- patient expects to place his/her hands under loading situations which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint
Exclusion Criteria:
- patient is not in need of a revision of a failed MCP prothesis(es)
- patient is eligible to use an alternative implant
Sites / Locations
- Hospital for Special Surgery
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT02244775
First Posted
September 12, 2014
Last Updated
September 18, 2014
Sponsor
Hospital for Special Surgery, New York
1. Study Identification
Unique Protocol Identification Number
NCT02244775
Brief Title
Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device
Official Title
Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device
Study Type
Expanded Access
2. Study Status
Record Verification Date
September 2014
Overall Recruitment Status
Approved for marketing
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital for Special Surgery, New York
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants for finger arthritis. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device.
Detailed Description
The purpose of this IRB approved study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device. Use of the SR™ MCP is approved for humanitarian use by the FDA when either the patient is in need of a revision of failed MCP prothesis(es) or the patient expects to place his/her hand under loading situation which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arthroplasty of the MCP Joint
Keywords
osteo-arthritis, post traumatic arthritis
7. Study Design
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
SR™MCP
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Eligibility Criteria
Inclusion Criteria:
patient is in need of a revision of failed MCP prosthesis(es)
patient expects to place his/her hands under loading situations which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint
Exclusion Criteria:
patient is not in need of a revision of a failed MCP prothesis(es)
patient is eligible to use an alternative implant
Facility Information:
Facility Name
Hospital for Special Surgery
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device
We'll reach out to this number within 24 hrs